CONGENITAL PARVOVIRUS B19 INFECTION

CONGENITAL PARVOVIRUS B19 INFECTION was reported 1 times

These drug classes are most commonly taken by patients reporting CONGENITAL PARVOVIRUS B19 INFECTION:

# Drug Count
0 Calcium [EPC] 1
1 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
2 Nonsteroidal Anti-inflammatory Drug [EPC] 1
3 Platelet Aggregation Inhibitor [EPC] 1